Impact of treatment line on TTNT for combination therapies. Patients receiving combination therapy as first-line, mid-line (second to fourth lines), or late-line (fifth line and greater) therapy had significantly different TTNT (median TTNT, 10.0 vs 6.2 vs 2.2 months; P < .001). The longest TTNT was with first-line use.